Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 7
Submit an article Journal homepage
3,646
Views
194
CrossRef citations to date
0
Altmetric
Special Focus: Vaccine Adjuvants - Review

The use of Toll-like receptor 7/8 agonists as vaccine adjuvants

John P Vasilakos Drug Delivery Systems Division, 3M Center, Building 260-4S-13, St Paul, MN 55144, USA. [email protected]; Drug Delivery Systems Division, 3M Center, Building 260-4S-13, St Paul, MN 55144, USA. [email protected]
&
Mark A Tomai MTS and Vaccine Business Development, 3M Drug Delivery Systems Division, 3M Center, Building 275-03-E-10, St Paul, MN 55144, USA; MTS and Vaccine Business Development, 3M Drug Delivery Systems Division, 3M Center, Building 275-03-E-10, St Paul, MN 55144, USA
Pages 809-819 | Published online: 09 Jan 2014

Citations (194)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani & Azam Bolhassani. (2021) The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Review of Vaccines 20:7, pages 839-855.
Read now
Eita Sasaki, Isao Hamaguchi & Takuo Mizukami. (2020) Pharmacodynamic and safety considerations for influenza vaccine and adjuvant design. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1051-1061.
Read now
Iordana Neamtu, Alina Gabriela Rusu, Alina Diaconu, Loredana Elena Nita & Aurica P. Chiriac. (2017) Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Delivery 24:1, pages 539-557.
Read now
Steven G Reed. (2013) Vaccine adjuvants. Expert Review of Vaccines 12:7, pages 705-706.
Read now

Articles from other publishers (190)

Lan Lei, Pengyuan Liu, Wu Jing & Zhibing Wu. (2023) Advancements in Modifying the Efficacy of Immunotherapies through the Thermal Effects of Nanomaterials. Nano TransMed, pages 100022.
Crossref
Weifan Ye, Yiwen Jia, Hongze Ren, Yujie Xie, Meihua Yu & Yu Chen. (2023) Regulation of Antigen‐Specific Immunotherapy with Nanomaterials. Advanced NanoBiomed Research.
Crossref
Venkatesan Saravanan, Bharath Kumar Chagaleti, Pavithra Lakshmi Narayanan, Vijay Babu Anandan, Haritha Manoharan, G.V. Anjana, Ramalingam Peraman, S. Karthik Raja Namasivayam, M. Kavisri, Jesu Arockiaraj, Kathiravan Muthu Kumaradoss & Meivelu Moovendhan. (2023) Discovery and development of COVID ‐19 vaccine from laboratory to clinic . Chemical Biology & Drug Design.
Crossref
Minliang Wu, Yuai Xiao, Jianguo Huang, Yuchong Wang, Yifan Zhang, Jianguo Xu, Haiying Dai, Chuan Lv, Yihui Hu, Bingdi Chen, Qingge Fu, Wenjun Le & Chunyu Xue. (2023) Liquid nitrogen frozen cells for chemotherapy drug delivery and vaccination of melanoma. Journal of Cancer Research and Clinical Oncology 149:15, pages 13705-13716.
Crossref
Yue Huang, Saifun Nahar, MD Masud Alam, Shuo Hu, Daniel W. McVicar & De Yang. (2023) Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment. ACS Nano 17:20, pages 19740-19752.
Crossref
Samik Chakraborty, Juan Ye, Herui Wang, Mitchell Sun, Yaping Zhang, Xueyu Sang & Zhengping Zhuang. (2023) Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. Frontiers in Immunology 14.
Crossref
Qiu-Yi Duan, Ya-Xuan Zhu, Hao-Ran Jia, Shi-Hao Wang & Fu-Gen Wu. (2023) Nanogels: Synthesis, properties, and recent biomedical applications. Progress in Materials Science 139, pages 101167.
Crossref
Narendra Kumar Nagendla, Seetha Bala Subrahanyam, Satyanand Konda & Mohana Krishna Reddy Mudiam. (2023) Development of liquid chromatography‐triple quadrupole mass spectrometric method for the quantitative determination of a novel adjuvant, Imidazoquinoline gallamide in aluminum hydroxide gel‐Imidazoquinoline gallamide and COVAXIN. Journal of Separation Science 46:20.
Crossref
Ming‐Yan Yang, Mei‐Hua Zheng, Xiang‐Ting Meng, Le‐Wei Ma, Hai‐Yue Liang & Hua‐Ying Fan. (2023) Role of toll‐like receptors in the pathogenesis of COVID ‐19: Current and future perspectives . Scandinavian Journal of Immunology 98:2.
Crossref
Wei Shi, Zhenzhen Tong, Shuang Chen, Qianqian Qiu, Jiaqi Zhou & Hai Qian. (2023) Development of novel self‐assembled vaccines based on tumour‐specific antigenic peptide and TLR2 agonist for effective breast cancer immunotherapy via activating CD8 + T cells and enhancing their function . Immunology 169:4, pages 454-466.
Crossref
Shuang Liang, Jianjun Yao, Dan Liu, Lang Rao, Xiaoyuan Chen & Zhaohui Wang. (2023) Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy. Advanced Materials 35:33.
Crossref
Hongze Ren, Wencong Jia, Yujie Xie, Meihua Yu & Yu Chen. (2023) Adjuvant physiochemistry and advanced nanotechnology for vaccine development. Chemical Society Reviews 52:15, pages 5172-5254.
Crossref
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu & Xiaohe Tian. (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy 8:1.
Crossref
Xudong Zhu & Shenglong Li. (2023) Nanomaterials in tumor immunotherapy: new strategies and challenges. Molecular Cancer 22:1.
Crossref
Raphael P. Viscidi, Treva Rowley & Ioannis Bossis. (2023) Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming. International Journal of Molecular Sciences 24:12, pages 9851.
Crossref
Johannes Lutz, Michael Meister, Mohamed Habbeddine, Katja Fiedler, Aleksandra Kowalczyk & Regina Heidenreich. (2022) Local immunotherapy with the RNA-based immune stimulator CV8102 induces substantial anti-tumor responses and enhances checkpoint inhibitor activity. Cancer Immunology, Immunotherapy 72:5, pages 1075-1087.
Crossref
Maria Agallou, Maritsa Margaroni, Evgenia Tsanaktsidou, Fotis Badounas, Olga Kammona, Costas Kiparissides & Evdokia Karagouni. (2023) A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes. Journal of Controlled Release 356, pages 386-401.
Crossref
Rika Wahyuningtyas, Mei-Li Wu, Wen-Bin Chung, Hso-Chi Chaung & Ko-Tung Chang. (2023) Toll-like Receptor-Mediated Immunomodulation of Th1-Type Response Stimulated by Recombinant Antigen of Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV-2). Viruses 15:3, pages 775.
Crossref
Li-rong Mao, Jian-peng Du, Xiao-chun Wang, Li-fa Xu, Yan-peng Zhang, Qi-shan Sun, Zi-lun Shi, Ying-ru Xing, Yi-xin Su, Sheng-jian Wang, Jian Wang, Ji-lei Ma & Jing-yan Zhang. (2023) Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG . ACS Infectious Diseases 9:3, pages 593-608.
Crossref
Wenzhu Yin, Bihua Deng, Zeyu Xu, Haiyan Wang, Fang Ma, Mingxu Zhou, Yu Lu & Jinqiu Zhang. (2023) Formulation and Evaluation of Lipidized Imiquimod as an Effective Adjuvant. ACS Infectious Diseases 9:2, pages 378-387.
Crossref
Fernando Augusto Siqueira Mathias, Thais Lopes Valentim Di Paschoale Ostolin, Levi Eduardo Soares Reis, Jamille Mirelle de Oliveira Cardoso, Rory Cristiane Fortes De Brito, Rodrigo Dian de Oliveira Aguiar Soares, Bruno Mendes Roatt, Paula Melo de Abreu Vieira & Alexandre Barbosa Reis. (2023) The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection. Vaccines 11:2, pages 395.
Crossref
Qian Yin, Wei Luo, Vamsee Mallajosyula, Yang Bo, Jing Guo, Jinghang Xie, Meng Sun, Rohit Verma, Chunfeng Li, Christian M. Constantz, Lisa E. Wagar, Jing Li, Elsa Sola, Neha Gupta, Chunlin Wang, Oliver Kask, Xin Chen, Xue Yuan, Nicholas C. Wu, Jianghong Rao, Yueh-hsiu Chien, Jianjun Cheng, Bali Pulendran & Mark M. Davis. (2023) A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2. Nature Materials.
Crossref
Ayyappa Avoni, Sravanthi Vemireddy, Shainy Sambyal, Syed Shafi, Imran Khan, Aarif Khan & Halmuthur M. Sampath Kumar. (2023) Synthesis and immunopharmacological evaluation of novel TLR7 agonistic triazole tethered imidazoquinolines. RSC Advances 13:2, pages 1066-1077.
Crossref
Ronnie Chamanza, Stuart W. Naylor & Jennifer A. Chilton. 2023. Spontaneous Pathology of the Laboratory Non-Human Primate. Spontaneous Pathology of the Laboratory Non-Human Primate 359 405 .
Irene Veneziani, Claudia Alicata, Lorenzo Moretta & Enrico Maggi. (2022) The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview. Biomedicines 11:1, pages 64.
Crossref
Ziyin Chen, Ziqi Yue, Kaiqi Yang & Shenglong Li. (2022) Nanomaterials: small particles show huge possibilities for cancer immunotherapy. Journal of Nanobiotechnology 20:1.
Crossref
M. A. Baryshnikova, A. V. Ponomarev, A. A. Rudakova, Z. A. Sokolova, N. V. Golubtsova, P. V. Tsarapaev, G. M. Levagina, E. D. Danilenko & V. S. Kosorukov. (2022) Comparison of Ridostin Pro and Poly(I:C) as adjuvant for a cancer neoantigen peptide vaccine. Russian Journal of Biotherapy 21:3, pages 82-89.
Crossref
David J. Dowling, Soumik Barman, Alyson J. Smith, Francesco Borriello, Danielle Chaney, Spencer E. Brightman, Gandolina Melhem, Byron Brook, Manisha Menon, Dheeraj Soni, Simone Schüller, Karthik Siram, Etsuro Nanishi, Hélène G. Bazin, David J. Burkhart, Ofer Levy & Jay T. Evans. (2022) Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination. Scientific Reports 12:1.
Crossref
Supreeda Tambunlertchai, Sean M. Geary & Aliasger K. Salem. (2022) Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment. Pharmaceutics 14:10, pages 2076.
Crossref
Abhijita Talukder, Chayanika Kalita, Nayanika Neog, Chayanika Goswami, Mrinal Kashyap Sarma & Iswar Hazarika. (2022) A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review. Zeitschrift für Naturforschung C 77:7-8, pages 351-362.
Crossref
Jian Ye, Bradley N Mills, Shuyang S Qin, Jesse Garrett-Larsen, Joseph D Murphy, Taylor P Uccello, Booyeon J Han, Tara G Vrooman, Carl J Johnston, Edith M Lord, Brian A Belt, David C Linehan & Scott A Gerber. (2022) Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. Journal for ImmunoTherapy of Cancer 10:7, pages e004784.
Crossref
Wenzhu Yin, Dechun Xuan, Haiyan Wang, Mingxu Zhou, Bihua Deng, Fang Ma, Yu Lu & Jinqiu Zhang. (2022) Biodegradable Imiquimod-Loaded Mesoporous Organosilica as a Nanocarrier and Adjuvant for Enhanced and Prolonged Immunity against Foot-and-Mouth Disease Virus in Mice. ACS Applied Bio Materials 5:6, pages 3095-3106.
Crossref
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Rosmely Hernandez & Thomas R. Malek. (2022) Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity. Frontiers in Oncology 12.
Crossref
Jianchun Zhou, Yu Xu, Guansong Wang, Tonghua Mei, Hao Yang & Yuliang Liu. (2022) The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer. International Journal of Oncology 61:1.
Crossref
YiTing Bai, TianRan Wang, SongLing Zhang, XueSi Chen & ChaoLiang He. (2022) Recent advances in organic and polymeric carriers for local tumor chemo-immunotherapy. Science China Technological Sciences 65:5, pages 1011-1028.
Crossref
K. K. Vidya Vijayan, Kaitlyn A. Cross, Alan D. CurtisIIII, Koen K. A. Van Rompay, Justin Pollara, Christopher B. Fox, Mark Tomai, Tomáš Hanke, Genevieve Fouda, Michael G. Hudgens, Sallie R. Permar & Kristina De Paris. (2022) Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques. Frontiers in Immunology 13.
Crossref
Hiroyuki Shinchi, Fumikazu Komaki, Masaharu Yuki, Haruka Ohara, Naohiro Hayakawa, Masahiro Wakao, Howard B. Cottam, Tomoko Hayashi, Dennis A. Carson, Toshiro Moroishi & Yasuo Suda. (2022) Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects. ACS Chemical Biology 17:4, pages 957-968.
Crossref
Wenzhu Yin, Dechun Xuan, Bihua Deng, Mingxu Zhou, Fang Ma, Jinqiu Zhang & Yu Lu. (2022) Vaccine adjuvant platform and fluorescence imaging of amphiphilic γ-PGA-IMQ-LA-FL conjugates. Materials Advances 3:5, pages 2505-2514.
Crossref
Huijuan Song, Qi Su, Weifeng Shi, Pingsheng Huang, Chuangnian Zhang, Chao Zhang, Qiang Liu & Weiwei Wang. (2022) Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy. Acta Biomaterialia 141, pages 398-407.
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Tetsuya Saito, Nikunj M. Shukla, Fumi Sato-Kaneko, Yukiya Sako, Tadashi Hosoya, Shiyin Yao, Fitzgerald S. Lao, Karen Messer, Minya Pu, Michael Chan, Paul J. Chu, Howard B. Cottam, Tomoko Hayashi, Dennis A. Carson & Maripat Corr. (2022) Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity. ACS Chemical Biology 17:1, pages 217-229.
Crossref
Yang Hao, Chih Kit Chung, Zhenfeng Yu, Ruben V. Huis in ‘t Veld, Ferry A. Ossendorp, Peter ten Dijke & Luis J. Cruz. (2022) Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy. Pharmaceutics 14:1, pages 120.
Crossref
Baharak Bahmani, Hua Gong, Brian T. Luk, Kristofer J. Haushalter, Ethel DeTeresa, Mark Previti, Jiarong Zhou, Weiwei Gao, Jack D. Bui, Liangfang Zhang, Ronnie H. Fang & Jie Zhang. (2021) Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors. Nature Communications 12:1.
Crossref
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Dan Xu, Sheng Jiang, Yue He, Xiang Jin, Gan Zhao & Bin Wang. (2021) Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma. npj Vaccines 6:1.
Crossref
Seung Mo Jin, Sang Nam Lee, Jung Eun Kim, Yeon Jeong Yoo, Chanyoung Song, Hong Sik Shin, Hathaichanok Phuengkham, Chang Hoon Lee, Soong Ho Um & Yong Taik Lim. (2021) Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension. Advanced Science 8:19.
Crossref
Sehwan Jeong, Yunyoung Choi & Kyobum Kim. (2021) Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists. Pharmaceutics 13:9, pages 1374.
Crossref
Nikunj M. Shukla, Michael Chan, Fitzgerald S. Lao, Paul J. Chu, Masiel Belsuzarri, Shiyin Yao, Jason Nan, Fumi Sato-Kaneko, Tetsuya Saito, Tomoko Hayashi, Maripat Corr, Dennis A. Carson & Howard B. Cottam. (2021) Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activation. Bioorganic & Medicinal Chemistry 43, pages 116242.
Crossref
Yi Yang, Adam Csakai, Shuangshuang Jiang, Christina Smith, Hiromi Tanji, Jian Huang, Torey Jones, Kentaro Sakaniwa, Lindsey Broadwell, Chengrui Shi, Subada Soti, Umeharu Ohto, Yaohui Fang, Shu Shen, Fei Deng, Toshiyuki Shimizu & Hang Yin. (2021) Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. Nature Communications 12:1.
Crossref
Dhruv Varshney, Sherry Yue Qiu, Tyler P. Graf & Kevin J. McHugh. (2021) Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy. The AAPS Journal 23:4.
Crossref
C. J. Massena, S. K. Lathrop, C. J. Davison, R. Schoener, H. G. Bazin, J. T. Evans & D. J. Burkhart. (2021) A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates. Chemical Communications 57:38, pages 4698-4701.
Crossref
Emrullah Korkmaz, Stephen C. Balmert, Tina L. Sumpter, Cara Donahue Carey, Geza Erdos & Louis D. FaloJrJr. (2021) Microarray patches enable the development of skin-targeted vaccines against COVID-19. Advanced Drug Delivery Reviews 171, pages 164-186.
Crossref
Guiqiang Zhang, Xiao Fu, Haifeng Sun, Peiyu Zhang, Shumei Zhai, Jingcheng Hao, Jiwei Cui & Ming Hu. (2021) Poly(ethylene glycol)-Mediated Assembly of Vaccine Particles to Improve Stability and Immunogenicity. ACS Applied Materials & Interfaces 13:12, pages 13978-13989.
Crossref
Colin D. Funk, Craig Laferrière & Ali Ardakani. (2021) Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective. Viruses 13:3, pages 418.
Crossref
G.P. DeMuriL.M. LehtorantaJ.C. EickhoffM.J. LehtinenE.R. Wald. (2021) Ex vivo peripheral blood mononuclear cell response to R848 in children after supplementation with the probiotic Lactobacillus acidophilus NCFM/ Bifidobacterium lactis Bi-07 . Beneficial Microbes 12:1, pages 85-93.
Crossref
Akhilesh Jha, Ryan S. Thwaites, Tanushree Tunstall, Onn Min Kon, Robin J. Shattock, Trevor T. Hansel & Peter J.M. Openshaw. (2021) Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis. Journal of Allergy and Clinical Immunology 147:2, pages 694-703.e12.
Crossref
Yudi Xu, Sheng Ma, Xinghui Si, Jiayu Zhao, Haiyang Yu, Lili Ma, Wantong Song & Zhaohui Tang. (2020) Polyethyleneimine‐CpG Nanocomplex as an In Situ Vaccine for Boosting Anticancer Immunity in Melanoma. Macromolecular Bioscience 21:2.
Crossref
Zhongtao Feng, Xin Yi & Jafar Hajavi. (2020) New and old adjuvants in allergen‐specific immunotherapy: With a focus on nanoparticles. Journal of Cellular Physiology 236:2, pages 863-876.
Crossref
Marina Luchner, Sören Reinke & Anita Milicic. (2021) TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics 13:2, pages 142.
Crossref
Shan Zhu, Ning Yang, Yi Guan, Xue Wang, Guoxia Zang, Xinping Lv, Shuanglin Deng, Wan Wang, Tete Li & Jingtao Chen. (2021) GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1/2–c-Fos–LIF signaling. Cell Death Discovery 7:1.
Crossref
Spyridon Makris & Cecilia Johansson. (2021) R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice. Mucosal Immunology 14:1, pages 267-276.
Crossref
Alexander K. Andrianov & Robert Langer. (2021) Polyphosphazene immunoadjuvants: Historical perspective and recent advances. Journal of Controlled Release 329, pages 299-315.
Crossref
Leopoldo Fabrício Marçal do Nascimento, Luana Dias de Moura, André Luis Souza dos Santos, Aarthy C Vallur & Maria do Socorro Pires e Cruz. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases 29 46 .
Bruna Renata Casadei, Mayra C.G. Lotierzo, Barbara Malheiros & Leandro R.S. Barbosa. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases 217 241 .
Koichi Fukase. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience 166 184 .
Payam Behzadi. 2021. Genetic Polymorphism and cancer susceptibility. Genetic Polymorphism and cancer susceptibility 281 317 .
Ali Keshavarz, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, Nader Bagheri, Seyed H. Ghaffari & Davood Bashash. (2020) Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists. IUBMB Life 73:1, pages 10-25.
Crossref
Azizul Haque & Anudeep B. Pant. (2020) Efforts at COVID-19 Vaccine Development: Challenges and Successes. Vaccines 8:4, pages 739.
Crossref
Floriane Auderset, Elodie Belnoue, Beatris Mastelic-Gavillet, Paul-Henri Lambert & Claire-Anne Siegrist. (2020) A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner. Frontiers in Immunology 11.
Crossref
Wen-Hao Li & Yan-Mei Li. (2020) Chemical Strategies to Boost Cancer Vaccines. Chemical Reviews 120:20, pages 11420-11478.
Crossref
Sören Reinke, Aneesh Thakur, Cillian Gartlan, Jelena S. Bezbradica & Anita Milicic. (2020) Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines 8:3, pages 554.
Crossref
Steven G Reed, Mark Tomai & Michael J GaleJr.Jr.. (2020) New horizons in adjuvants for vaccine development. Current Opinion in Immunology 65, pages 97-101.
Crossref
Junqing Wang, Harshal Zope, Mohammad Ariful Islam, Jamie Rice, Sage Dodman, Kevin Lipert, Yunhan Chen, Bruce R. Zetter & Jinjun Shi. (2020) Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Daniel E. Speiser & Martin F. Bachmann. (2020) COVID-19: Mechanisms of Vaccination and Immunity. Vaccines 8:3, pages 404.
Crossref
Ivo B. Regli, Katiuska Passelli, Berenice Martínez-Salazar, Jonas Amore, Benjamin P. Hurrell, Andreas J. Müller & Fabienne Tacchini-Cottier. (2020) TLR7 Sensing by Neutrophils Is Critical for the Control of Cutaneous Leishmaniasis. Cell Reports 31:10, pages 107746.
Crossref
Yibo Wang, Shuting Zhang, Hongyuan Li, Hongshuang Wang, Tianshu Zhang, Mark R. Hutchinson, Hang Yin & Xiaohui Wang. (2020) Small-Molecule Modulators of Toll-like Receptors. Accounts of Chemical Research 53:5, pages 1046-1055.
Crossref
Alexander K. Andrianov, Alexander Marin, Ruixue Wang, Hatice Karauzum, Ananda Chowdhury, Pragati Agnihotri, Abdul S. Yunus, Roy A. Mariuzza & Thomas R. Fuerst. (2020) Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo . ACS Applied Bio Materials 3:5, pages 3187-3195.
Crossref
Cindy Patinote, Nour Bou Karroum, Georges Moarbess, Natalina Cirnat, Issam Kassab, Pierre-Antoine Bonnet & Carine Deleuze-Masquéfa. (2020) Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes. European Journal of Medicinal Chemistry 193, pages 112238.
Crossref
Zhi-Biao Wang & Jing Xu. (2020) Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery. Vaccines 8:1, pages 128.
Crossref
Geoffrey M. Lynn, Christine Sedlik, Faezzah Baharom, Yaling Zhu, Ramiro A. Ramirez-Valdez, Vincent L. Coble, Kennedy Tobin, Sarah R. Nichols, Yaakov Itzkowitz, Neeha Zaidi, Joshua M. Gammon, Nicolas J. Blobel, Jordan Denizeau, Philippe de la Rochere, Brian J. Francica, Brennan Decker, Mateusz Maciejewski, Justin Cheung, Hidehiro Yamane, Margery G. Smelkinson, Joseph R. Francica, Richard Laga, Joshua D. Bernstock, Leonard W. Seymour, Charles G. Drake, Christopher M. Jewell, Olivier Lantz, Eliane Piaggio, Andrew S. Ishizuka & Robert A. Seder. (2020) Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens. Nature Biotechnology 38:3, pages 320-332.
Crossref
Hélène G. Bazin, Laura S. Bess, Mark T. Livesay, Yufeng Li, Van Cybulski, Shannon M. Miller, David A. Johnson & Jay T. Evans. (2020) Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity. Bioorganic & Medicinal Chemistry Letters 30:6, pages 126984.
Crossref
Jingchao Xi & Haipeng Liu. (2019) Recent Advances in the Design of Self‐Delivery Amphiphilic Drugs and Vaccines. Advanced Therapeutics 3:2.
Crossref
Hans-Uwe Simon, Alexander V. Karaulov & Martin F. Bachmann. (2020) Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection. International Archives of Allergy and Immunology 181:8, pages 624-628.
Crossref
Nicola Luigi Bragazzi, Ashraf Hejly, Abdulla Watad, Mohammed Adawi, Howard Amital & Yehuda Shoenfeld. (2020) ASIA syndrome and endocrine autoimmune disorders. Best Practice & Research Clinical Endocrinology & Metabolism 34:1, pages 101412.
Crossref
Michael Chan, Fitzgerald S. Lao, Paul J. Chu, Jonathan Shpigelman, Shiyin Yao, Jason Nan, Fumi Sato-Kaneko, Vicky Li, Tomoko Hayashi, Maripat Corr, Dennis A. Carson, Howard B. Cottam & Nikunj M. Shukla. (2019) Structure–Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli. Journal of Medicinal Chemistry 62:21, pages 9521-9540.
Crossref
Alice Comberlato, Kaltrina Paloja & Maartje M. C. Bastings. (2019) Nucleic acids presenting polymer nanomaterials as vaccine adjuvants. Journal of Materials Chemistry B 7:41, pages 6321-6346.
Crossref
Jay T. Evans, Laura S. Bess, Sandra C. Mwakwari, Mark T. Livesay, Yufeng Li, Van Cybulski, David A. Johnson & Hélène G. Bazin. (2019) Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series. ACS Omega 4:13, pages 15665-15677.
Crossref
Francisco A. Venegas, Gabriele Köllisch, Kerstin Mark, Wibke E. Diederich, Andreas Kaufmann, Stefan Bauer, Max Chavarría, Juan J. Araya & Alfonso J. García-Piñeres. (2019) The Bacterial Product Violacein Exerts an Immunostimulatory Effect Via TLR8. Scientific Reports 9:1.
Crossref
Rebecca S. Rudicell, Marie Garinot, Masaru Kanekiyo, Heather D. Kamp, Kurt Swanson, Te-hui Chou, Shujia Dai, Olivier Bedel, Daniel Simard, Rebecca A. Gillespie, Kanwen Yang, Michael Reardon, Luis Z. Avila, Magnus Besev, Pradeep K. Dhal, Ram Dharanipragada, Lingyi Zheng, Xiaochu Duan, Joshua Dinapoli, Thorsten U. Vogel, Harry Kleanthous, John R. Mascola, Barney S. Graham, Jean Haensler, Chih-Jen Wei & Gary J. Nabel. (2019) Comparison of adjuvants to optimize influenza neutralizing antibody responses. Vaccine 37:42, pages 6208-6220.
Crossref
Tao Hu, Haiyang Yu, Min Lu, Xiaoling Yuan, Xuan Wu, Huan Qiu, Jason Chen & Shenghai Huang. (2019) TLR4 and nucleolin influence cell injury, apoptosis and inflammatory factor expression in respiratory syncytial virus‐infected N2a neuronal cells. Journal of Cellular Biochemistry 120:9, pages 16206-16218.
Crossref
Philipp Georg & Leif E Sander. (2019) Innate sensors that regulate vaccine responses. Current Opinion in Immunology 59, pages 31-41.
Crossref
Tuan Hiep Tran, Thi Thu Phuong Tran, Duy Hieu Truong, Hanh Thuy Nguyen, Tung Thanh Pham, Chul Soon Yong & Jong Oh Kim. (2019) Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy. Acta Biomaterialia 94, pages 82-96.
Crossref
Leopoldo Fabrício Marçal do Nascimento, Luana Dias de Moura, Rebecca Tavares Lima & Maria do Socorro Pires e Cruz. (2019) Novos adjuvantes vacinais: importante ferramenta para imunoterapia da leishmaniose visceral. HU Revista 44:3, pages 401-410.
Crossref
Gregory Q. Del Prete, W. Gregory Alvord, Yuan Li, Claire Deleage, Mukta Nag, Kelli Oswald, James A. Thomas, Cathi Pyle, William J. Bosche, Vicky Coalter, Adam Wiles, Rodney Wiles, Brian Berkemeier, Michael Hull, Elizabeth Chipriano, Lorna Silipino, Randy Fast, Jacob Kiser, Rebecca Kiser, Tyler Malys, Joshua Kramer, Matthew W. Breed, Charles M. Trubey, Jacob D. Estes, Tiffany L. Barnes, Joseph Hesselgesser, Romas Geleziunas & Jeffrey D. Lifson. (2019) TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia. JCI Insight 4:11.
Crossref
Anna K. Blakney, Paul F. McKay, Dennis Christensen, Bárbara Ibarzo Yus, Yoann Aldon, Frank Follmann & Robin J. Shattock. (2019) Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA. Journal of Controlled Release 304, pages 65-74.
Crossref
Ning Wang, Minnan Chen & Ting Wang. (2019) Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization. Journal of Controlled Release 303, pages 130-150.
Crossref
Richard Moreau, Axel Périanin & Vicente Arroyo. (2019) Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis. Frontiers in Immunology 10.
Crossref
Pamela A. Kozlowski & Anna Aldovini. (2019) Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission. Current Immunology Reviews 15:1, pages 102-122.
Crossref
Fatma Doener, Henoch S. Hong, Ingo Meyer, Keyvan Tadjalli-Mehr, Angelika Daehling, Regina Heidenreich, Sven D. Koch, Mariola Fotin-Mleczek & Ulrike Gnad-Vogt. (2019) RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial. Vaccine 37:13, pages 1819-1826.
Crossref
W. Song, M. Das, Y. Xu, X. Si, Y. Zhang, Z. Tang & X. Chen. (2019) Leveraging biomaterials for cancer immunotherapy: targeting pattern recognition receptors. Materials Today Nano 5, pages 100029.
Crossref
Sudhir Agrawal & Ekambar R. Kandimalla. 2019. Advances in Nucleic Acid Therapeutics. Advances in Nucleic Acid Therapeutics 306 338 .
Apriliana E. R. Kartikasari, Monica D. Prakash, Momodou Cox, Kirsty Wilson, Jennifer C. Boer, Jennifer A. Cauchi & Magdalena Plebanski. (2019) Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation. Frontiers in Immunology 9.
Crossref
Yao Lei, Furong Zhao, Junjun Shao, Yangfan Li, Shifang Li, Huiyun Chang & Yongguang Zhang. (2019) Application of built-in adjuvants for epitope-based vaccines. PeerJ 6, pages e6185.
Crossref
Victor R. DeFilippis. 2019.
Gordana Halec, Mark E. Scott, Sepideh Farhat, Teresa M. Darragh & Anna‐Barbara Moscicki. (2018) Toll‐like receptors: Important immune checkpoints in the regression of cervical intra‐epithelial neoplasia 2. International Journal of Cancer 143:11, pages 2884-2891.
Crossref
Eita Sasaki, Haruka Momose, Yuki Hiradate, Takuo Mizukami & Isao Hamaguchi. (2018) Establishment of a novel safety assessment method for vaccine adjuvant development. Vaccine 36:46, pages 7112-7118.
Crossref
Bonnie Phillips, Koen K. A. Van Rompay, Jennifer Rodriguez-Nieves, Clarisse Lorin, Marguerite Koutsoukos, Mark Tomai, Christopher B. Fox, Josh Eudailey, Maria Dennis, S. Munir Alam, Michael Hudgens, Genevieve Fouda, Justin Pollara, Anthony Moody, Xiaoying Shen, Guido Ferrari, Sallie Permar & Kristina De Paris. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. Journal of Virology 92:20.
Crossref
Can Li, Kelvin K. W. To, Anna J. X. Zhang, Andrew C. Y. Lee, Houshun Zhu, Winger W. N. Mak, Ivan F. N. Hung & Kwok-Yung Yuen. (2018) Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production. Frontiers in Immunology 9.
Crossref
Emanuele Albano & Felix Stickel. (2018) Targeting toll-like receptor 7/8 improves host anti-infective response in alcoholic cirrhosis. Gut 67:10, pages 1749-1750.
Crossref
Gang Lu, Jian Zhou, Ying hui Zhao & Lin Wang. (2018) DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice . Parasite Immunology 40:10, pages e12578.
Crossref
Damien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, Marilène Bolduc, Michel Duval, Pierre Savard & Denis Leclerc. (2018) Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist. Nanomedicine: Nanotechnology, Biology and Medicine 14:7, pages 2317-2327.
Crossref
Neal Van Hoeven, Steven Wiley, Emily Gage, Andrew Fiore-Gartland, Brian Granger, Sean Gray, Christopher Fox, David E. Clements, D. Elliot Parks, Scott Winram, Dan T. Stinchcomb, Steven G. Reed & Rhea N. Coler. (2018) A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen. npj Vaccines 3:1.
Crossref
Mosayeb Rostamian, Fariborz Bahrami & Hamid M. Niknam. (2018) Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice. PLOS ONE 13:9, pages e0204491.
Crossref
Lutz Nuhn, Lien Van Hoecke, Kim Deswarte, Bert Schepens, Yupeng Li, Bart N. Lambrecht, Stefaan De Koker, Sunil A. David, Xavier Saelens & Bruno G. De Geest. (2018) Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. Biomaterials 178, pages 643-651.
Crossref
Burcu Temizoz, Etsushi Kuroda & Ken J Ishii. (2018) Combination and inducible adjuvants targeting nucleic acid sensors. Current Opinion in Pharmacology 41, pages 104-113.
Crossref
David J. Dowling. (2018) Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants. ImmunoHorizons 2:6, pages 185-197.
Crossref
Padma Malyala, Donatello Laera, Simona Cianetti, Simone Bufali, Marianna Aggravi, Elvira Ianni, Casey Judge, Gillis Otten, Manmohan Singh & Derek T. O'Hagan. (2018) The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum Hydroxide. Journal of Pharmaceutical Sciences 107:6, pages 1577-1585.
Crossref
Hyunjoon Kim, Lin Niu, Peter Larson, Tamara A. Kucaba, Katherine A. Murphy, Britnie R. James, David M. Ferguson, Thomas S. Griffith & Jayanth Panyam. (2018) Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. Biomaterials 164, pages 38-53.
Crossref
Qian Wang, Meagan A. Barry, Christopher A. Seid, Elissa M. Hudspeth, C. Patrick McAtee & Michael J. Heffernan. (2018) 3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine . Journal of Biomedical Materials Research Part B: Applied Biomaterials 106:4, pages 1587-1594.
Crossref
Rie Wakabayashi, Masato Sakuragi, Shuto Kozaka, Yoshiro Tahara, Noriho Kamiya & Masahiro Goto. (2018) Solid-in-Oil Peptide Nanocarriers for Transcutaneous Cancer Vaccine Delivery against Melanoma. Molecular Pharmaceutics 15:3, pages 955-961.
Crossref
Naoto Nishii, Hidetake Tachinami, Yuta Kondo, Yulong Xia, Yoshihisa Kashima, Tatsukuni Ohno, Shigenori Nagai, Lixin Li, Walter Lau, Hiroyuki Harada & Miyuki Azuma. (2018) Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. Oncotarget 9:17, pages 13301-13312.
Crossref
Beth C. Holbrook, S. Tyler Aycock, Emily Machiele, Elene Clemens, Danielle Gries, Matthew J. Jorgensen, Mallinath B. Hadimani, S. Bruce King & Martha A. Alexander-Miller. (2018) An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates. Immunology 153:3, pages 357-367.
Crossref
Marlena M. Westcott, Elene A. Clemens, Beth C. Holbrook, S. Bruce King & Martha A. Alexander-Miller. (2018) The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells. Vaccine 36:9, pages 1174-1182.
Crossref
Costanza Angelini, Barbara Varano, Patrizia Puddu, Maurizio Fiori, Antonella Baldassarre, Andrea Masotti, Sandra Gessani & Lucia Conti. (2017) Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14+CD16+ Monocytes and γδ T Lymphocytes. Frontiers in Immunology 8.
Crossref
Kelly C.G. Manfrere, Marina P. Torrealba, Denis R. Miyashiro, Nátalli Z. Pereira, Fabio S.Y. Yoshikawa, Luana de M. Oliveira, Jade Cury-Martins, Alberto J.S. Duarte, José A. Sanches & Maria N. Sato. (2017) Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome. Oncotarget 8:54, pages 92183-92194.
Crossref
Fabien Pitoiset, Thomas Vazquez, Beatrice Levacher, Djamel Nehar-Belaid, Nicolas Dérian, James Vigneron, David Klatzmann & Bertrand Bellier. (2017) Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation. Journal of Virology 91:21.
Crossref
Mosayeb Rostamian & Hamid M. Niknam. (2017) Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice. Molecular Immunology 91, pages 202-208.
Crossref
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Mariela A. Moreno Ayala, María Florencia Gottardo, María Soledad Gori, Alejandro Javier Nicola Candia, Carla Caruso, Andrea De Laurentiis, Mercedes Imsen, Slobodanka Klein, Elisa Bal de Kier Joffé, Gabriela Salamone, Maria G. Castro, Adriana Seilicovich & Marianela Candolfi. (2017) Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer. Journal of Cancer Research and Clinical Oncology 143:9, pages 1713-1732.
Crossref
Ingrid M. Leal Rojas, Wai-Hong Mok, Frances E. Pearson, Yoshihito Minoda, Tony J. Kenna, Ross T. Barnard & Kristen J. Radford. (2017) Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells. Frontiers in Immunology 8.
Crossref
Michael Chan, Alast Ahmadi, Shiyin Yao, Fumi Sato-Kaneko, Karen Messer, Minya Pu, Brandon Nguyen, Tomoko Hayashi, Maripat Corr, Dennis A. Carson, Howard B. Cottam & Nikunj M. Shukla. (2017) Identification of Biologically Active Pyrimido[5,4- b ]indoles That Prolong NF-κB Activation without Intrinsic Activity . ACS Combinatorial Science 19:8, pages 533-543.
Crossref
Amir Fakhari, Sean Nugent, James Elvecrog, John Vasilakos, Marta Corcoran, Ashenafi Tilahun, Kristen Siebenaler, Jenny Sun, J. Anand Subramony & Alexander Schwarz. (2017) Thermosensitive Gel–Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197. Journal of Pharmaceutical Sciences 106:8, pages 2037-2045.
Crossref
S. De Koker, L. Van Hoecke, A. De Beuckelaer, K. Roose, K. Deswarte, M. A. Willart, P. Bogaert, T. Naessens, B. G. De Geest, X. Saelens, B. N. Lambrecht & J. Grooten. (2017) Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12. Scientific Reports 7:1.
Crossref
Yu-Han Wen, Tsung-Ying Lee, Ping-Chuan Fu, Chun-Liang Lo & Yi-Ting Chiang. (2017) Multifunctional Polymer Nanoparticles for Dual Drug Release and Cancer Cell Targeting. Polymers 9:12, pages 213.
Crossref
Carlos Kubli-Garfias, Ricardo Vázquez-Ramírez, Cynthia Trejo-Muñoz & Arturo Berber. (2017) Insights on the mechanism of action of immunostimulants in relation to their pharmacological potency. The effects of imidazoquinolines on TLR8. PLOS ONE 12:6, pages e0178846.
Crossref
Ranjna Madan-Lala, Pallab Pradhan & Krishnendu Roy. (2017) Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses. Scientific Reports 7:1.
Crossref
Peipei Wu, Jihu Lu, Lei Feng, Hongzhuan Wu, Xuehua Zhang, Mei Mei, Jibo Hou, Xiufan Liu & Yinghua Tang. (2017) Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens. Frontiers in Microbiology 8.
Crossref
Neal Van Hoeven, Christopher B. Fox, Brian Granger, Tara Evers, Sharvari W. Joshi, Ghislain I. Nana, Sarah C. Evans, Susan Lin, Hong Liang, Li Liang, Rie Nakajima, Philip L. Felgner, Richard A. Bowen, Nicole Marlenee, Airn Hartwig, Susan L. Baldwin, Rhea N. Coler, Mark Tomai, James Elvecrog, Steven G. Reed & Darrick Carter. (2017) A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines. Scientific Reports 7:1.
Crossref
Angela Tsai, Alivelu Irrinki, Jasmine Kaur, Tomas Cihlar, George Kukolj, Derek D. Sloan & Jeffrey P. Murry. (2017) Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy. Journal of Virology 91:8.
Crossref
Till S.M. Mathan, Johannes Textor, Annette E. Sköld, Inge Reinieren-Beeren, Tom van Oorschot, Mareke Brüning, Carl G. Figdor, Sonja I. Buschow, Ghaith Bakdash & I. Jolanda M. de Vries. (2017) Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy. Oncotarget 8:12, pages 19879-19893.
Crossref
Momoko Kitaoka, Ayaka Naritomi, Yoshinori Kawabe, Masamichi Kamihira, Noriho Kamiya & Masahiro Goto. (2017) Transcutaneous pollinosis immunotherapy using a solid-in-oil nanodispersion system carrying T cell epitope peptide and R848. Bioengineering & Translational Medicine 2:1, pages 102-108.
Crossref
Sema Sevimli, Frances C. Knight, Pavlo Gilchuk, Sebastian Joyce & John T. Wilson. (2016) Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants. ACS Biomaterials Science & Engineering 3:2, pages 179-194.
Crossref
Chike F. Oguejiofor, Zhangrui Cheng, Ali A. Fouladi-Nashta & D. Claire Wathes. (2017) Bovine Endometrial Cells Mount Innate Immune Response to the Intracellular Ligands CL097 and Poly(dA:dT) Indicating Roles against Uterine Viruses. Open Journal of Animal Sciences 07:02, pages 110-126.
Crossref
Wenjing Lin, Samuel Hanson, Wenqing Han, Xiaofang Zhang, Na Yao, Hongru Li, Lijuan Zhang & Chun Wang. (2017) Well-defined star polymers for co-delivery of plasmid DNA and imiquimod to dendritic cells. Acta Biomaterialia 48, pages 378-389.
Crossref
M.A. Tomai & J.P. Vasilakos. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines 149 162 .
C. Buonsanti & U. D'Oro. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines 85 104 .
Ji-Kun Li, Jesse J. Balic, Liang Yu & Brendan Jenkins. 2017. Regulation of Inflammatory Signaling in Health and Disease. Regulation of Inflammatory Signaling in Health and Disease 195 212 .
Gervais Rioux, Damien Carignan, Alexis Russell, Marilène Bolduc, Marie-Ève Laliberté Gagné, Pierre Savard & Denis Leclerc. (2016) Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine. Journal of Nanobiotechnology 14:1.
Crossref
Kayoko Waki & Akira Yamada. (2016) Blockade of high mobility group box 1 augments antitumor T ‐cell response induced by peptide vaccination as a co‐adjuvant . Cancer Science 107:12, pages 1721-1729.
Crossref
Robert A. Mitchell, Rita Altszuler, Ute Frevert & Elizabeth H. Nardin. (2016) Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity. Scientific Reports 6:1.
Crossref
Christopher B. Fox, Mark T. Orr, Neal Van Hoeven, Sarah C. Parker, Traci J.T. Mikasa, Tony Phan, Elyse A. Beebe, Ghislain I. Nana, Sharvari W Joshi, Mark A. Tomai, James Elvecrog, Timothy R. Fouts & Steven G. Reed. (2016) Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach. Journal of Controlled Release 244, pages 98-107.
Crossref
F. C. Mansilla, M. E. Quintana, N. P. Cardoso & A. V. Capozzo. (2016) Fusion of foreign T-cell epitopes and addition of TLR agonists enhance immunity against Neospora caninum profilin in cattle . Parasite Immunology 38:11, pages 663-669.
Crossref
Han-Ha Chai, Dajeong Lim, Jae Eun Suk, Bong-Hwan Choi & Yong-Min Cho. (2016) Design of anti-BVDV drug based on common chemical features, their interaction, and scaffolds of TLR8 agonists. International Journal of Biological Macromolecules 92, pages 1095-1112.
Crossref
Christopher P. Karch & Peter Burkhard. (2016) Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochemical Pharmacology 120, pages 1-14.
Crossref
M Zeng, E Nourishirazi, E Guinet & M Nouri-Shirazi. (2016) The genetic background influences the cellular and humoral immune responses to vaccines. Clinical and Experimental Immunology 186:2, pages 190-204.
Crossref
Matthew D. Gallovic, Kevin L. Schully, Matthew G. Bell, Margaret A. Elberson, John R. Palmer, Christian A. Darko, Eric M. Bachelder, Barbara E. Wyslouzil, Andrea M. Keane-Myers & Kristy M. Ainslie. (2016) Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure . Advanced Healthcare Materials 5:20, pages 2617-2627.
Crossref
Babatope Akinbobuyi, Lei Wang, Katherine C. Upchurch, Matthew R. Byrd, Charles A. Chang, Jeremy M. Quintana, Rachel E. Petersen, Zacharie J. Seifert, José R. Boquin, SangKon Oh & Robert R. Kane. (2016) Synthesis and immunostimulatory activity of substituted TLR7 agonists. Bioorganic & Medicinal Chemistry Letters 26:17, pages 4246-4249.
Crossref
Alyson J. Smith, Yufeng Li, Hélène G. Bazin, Julien R. St-Jean, Daniel Larocque, Jay T. Evans & Jory R. Baldridge. (2016) Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants. Vaccine 34:36, pages 4304-4312.
Crossref
Elodie Mohr & Claire-Anne Siegrist. (2016) Vaccination in early life: standing up to the challenges. Current Opinion in Immunology 41, pages 1-8.
Crossref
Beth C. Holbrook, Jong R. Kim, Lance K. Blevins, Matthew J. Jorgensen, Nancy D. Kock, Ralph B. D’AgostinoJr.Jr., S. Tyler Aycock, Mallinath B. Hadimani, S. Bruce King, Griffith D. Parks & Martha A. Alexander-Miller. (2016) A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model. The Journal of Immunology 197:2, pages 555-564.
Crossref
Caroline J. Breitbach, Brian D. Lichty & John C. Bell. (2016) Oncolytic Viruses: Therapeutics With an Identity Crisis. EBioMedicine 9, pages 31-36.
Crossref
Saleh Al-Quraishy, Mohamed A. Dkhil, Suliman Alomar, Abdel Azeem S. Abdel-Baki, Denis Delic, Frank Wunderlich & Marcos J. Araúzo-Bravo. (2016) Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice. Parasitology Research 115:5, pages 1835-1843.
Crossref
Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, Angela Bosco-Lauth, Christopher Fox, Richard A. Bowen, David E. Clements, Timothy Martyak, D. Elliot Parks, Susan Baldwin, Steven G. Reed & Rhea N. Coler. (2016) A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. PLOS ONE 11:2, pages e0149610.
Crossref
Guorui Xie, Huanle Luo, Lan Pang, Bi-hung Peng, Evandro Winkelmann, Brenna McGruder, Joseph Hesse, Melissa Whiteman, Gerald Campbell, Gregg N. Milligan, Yingzi Cong, Alan D. Barrett & Tian Wang. (2016) Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice. Journal of Virology 90:3, pages 1333-1344.
Crossref
Francesca Mancini, Elisabetta Monaci, Giuseppe Lofano, Antonina Torre, Marta Bacconi, Simona Tavarini, Chiara Sammicheli, Letizia Arcidiacono, Bruno Galletti, Donatello Laera, Michele Pallaoro, Giovanna Tuscano, Maria Rita Fontana, Giuliano Bensi, Guido Grandi, Silvia Rossi-Paccani, Sandra Nuti, Rino Rappuoli, Ennio De Gregorio, Fabio Bagnoli, Elisabetta Soldaini & Sylvie Bertholet. (2016) One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. PLOS ONE 11:1, pages e0147767.
Crossref
Anurag Adhikari, Birendra Prasad Gupta, Krishna Das Manandhar, Shravan Kumar Mishra, Hari Krishna Saiju, Rajendra Maan Shrestha, Nawneet Mishra & Shishir Sharma. (2015) Negative feedback circuit for toll like receptor-8 activation in human embryonic Kidney 293 using outer membrane vesicle delivered bi-specific siRNA. BMC Immunology 16:1.
Crossref
Fen Pei, Hongwei Jin, Xin Zhou, Jie Xia, Lidan Sun, Zhenming Liu & Liangren Zhang. (2015) Enrichment Assessment of Multiple Virtual Screening Strategies for Toll-Like Receptor 8 Agonists Based on a Maximal Unbiased Benchmarking Data Set. Chemical Biology & Drug Design 86:5, pages 1226-1241.
Crossref
Eric L Dane & Darrell J Irvine. (2015) Big thinking for adjuvants. Nature Biotechnology 33:11, pages 1146-1148.
Crossref
K.L. Schully, M.G. Bell, A.M. Prouty, M.D. Gallovic, S. Gautam, K.J. Peine, S. Sharma, E.M. Bachelder, J.T. Pesce, M.A. Elberson, K.M. Ainslie & A. Keane-Myers. (2015) Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis. International Journal of Pharmaceutics 495:2, pages 849-861.
Crossref
Annette E. Sköld, Jasper J. P. van Beek, Simone P. Sittig, Ghaith Bakdash, Jurjen Tel, Gerty Schreibelt & I. Jolanda M. de Vries. (2015) Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets. Cancer Immunology, Immunotherapy 64:11, pages 1461-1473.
Crossref
Martin Kreutz, Ghaith Bakdash, Yusuf Dolen, Annette E. Sköld, Maaike A. van Hout-Kuijer, I. Jolanda M. de Vries & Carl G. Figdor. (2015) Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists. European Journal of Immunology 45:10, pages 2798-2809.
Crossref
Sankarasubramanian Rajaram & Helen Bright. (2015) Commentary on articles published on 2010 Southern Hemisphere Trivalent Influenza Vaccine association with adverse events. Vaccine 33:29, pages 3271-3272.
Crossref
Hidekazu Shirota, Debra Tross & Dennis Klinman. (2015) CpG Oligonucleotides as Cancer Vaccine Adjuvants. Vaccines 3:2, pages 390-407.
Crossref
Tomofumi Uto, Takami Akagi, Mitsuru Akashi & Masanori Baba. (2015) Induction of Potent Adaptive Immunity by the Novel Polyion Complex Nanoparticles. Clinical and Vaccine Immunology 22:5, pages 578-585.
Crossref
Stephanie Jung, Tina von Thülen, Viktoria Laukemper, Stephanie Pigisch, Doris Hangel, Hermann Wagner, Andreas Kaufmann & Stefan Bauer. (2015) A Single Naturally Occurring 2’-O-Methylation Converts a TLR7- and TLR8-Activating RNA into a TLR8-Specific Ligand. PLOS ONE 10:3, pages e0120498.
Crossref
Anabel Silva, Adele Mount, Karoline Krstevska, David Pejoski, Matthew P. Hardy, Catherine Owczarek, Pierre Scotney, Eugene Maraskovsky & Adriana Baz Morelli. (2015) The Combination of ISCOMATRIX Adjuvant and TLR Agonists Induces Regression of Established Solid Tumors In Vivo. The Journal of Immunology 194:5, pages 2199-2207.
Crossref
Rachel Lubong Sabado, Anna Pavlick, Sacha Gnjatic, Crystal M. Cruz, Isabelita Vengco, Farah Hasan, Meredith Spadaccia, Farbod Darvishian, Luis Chiriboga, Rose Marie Holman, Juliet Escalon, Caroline Muren, Crystal Escano, Ethel Yepes, Dunbar Sharpe, John P. Vasilakos, Linda Rolnitzsky, Judith D. Goldberg, John Mandeli, Sylvia Adams, Achim Jungbluth, Linda Pan, Ralph Venhaus, Patrick A. Ott & Nina Bhardwaj. (2015) Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma. Cancer Immunology Research 3:3, pages 278-287.
Crossref
Michael W. Graner, Kevin O. Lillehei & Emmanuel Katsanis. (2015) Endoplasmic Reticulum Chaperones and Their Roles in the Immunogenicity of Cancer Vaccines. Frontiers in Oncology 4.
Crossref
Elfi Töpfer, Diana Boraschi & Paola Italiani. (2015) Innate Immune Memory: The Latest Frontier of Adjuvanticity. Journal of Immunology Research 2015, pages 1-7.
Crossref
O. Palomares, R. Crameri & C. Rhyner. (2014) The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases. Allergy 69:12, pages 1588-1601.
Crossref
Euna Yoo, Deepak B. Salunke, Diptesh Sil, Xiaoqiang Guo, Alex C. D. Salyer, Alec R. Hermanson, Manoj Kumar, Subbalakshmi S. Malladi, Rajalakshmi Balakrishna, Ward H. Thompson, Hiromi Tanji, Umeharu Ohto, Toshiyuki Shimizu & Sunil A. David. (2014) Determinants of Activity at Human Toll-like Receptors 7 and 8: Quantitative Structure–Activity Relationship (QSAR) of Diverse Heterocyclic Scaffolds. Journal of Medicinal Chemistry 57:19, pages 7955-7970.
Crossref
Lucia Filì, Elisa Cardilicchia, Enrico Maggi & Paola Parronchi. (2014) Perspectives in vaccine adjuvants for allergen-specific immunotherapy. Immunology Letters 161:2, pages 207-210.
Crossref
Preety Sahdev, Lukasz J. Ochyl & James J. Moon. (2014) Biomaterials for Nanoparticle Vaccine Delivery Systems. Pharmaceutical Research 31:10, pages 2563-2582.
Crossref
Noah Craft, Ron Birnbaum, Natalie Quanquin, Marie Crisel B. Erfe, Cara Quant, Jacquelyn Haskell & Kevin W. Bruhn. (2014) Topical Resiquimod Protects against Visceral Infection with Leishmania infantum chagasi in Mice. Clinical and Vaccine Immunology 21:9, pages 1314-1322.
Crossref
Chao-Yang Lai, Yi-Ling Liu, Guann-Yi Yu, Ming-Chei Maa, Tzeng-Horng Leu, Congfeng Xu, Yunping Luo, Rong Xiang & Tsung-Hsien Chuang. (2014) TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7. Vaccine 32:43, pages 5593-5599.
Crossref
Luis A. Brito & Derek T. O'Hagan. (2014) Designing and building the next generation of improved vaccine adjuvants. Journal of Controlled Release 190, pages 563-579.
Crossref
Moonkyu Lee, Chan-Su Park, Young-Ran Lee, Sun-A Im, Sukgil Song & Chong-Kil Lee. (2014) Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells. Archives of Pharmacal Research 37:9, pages 1234-1240.
Crossref
Kirsteen M. Tullett, Mireille H. Lahoud & Kristen J. Radford. (2014) Harnessing Human Cross-Presenting CLEC9A+XCR1+ Dendritic Cells for Immunotherapy. Frontiers in Immunology 5.
Crossref
Auris O. Huen & Alain H. Rook. (2014) Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Current Opinion in Oncology 26:2, pages 237-244.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.